Glycoprotein C of herpes simplex virus type 1 prevents complement-mediated cell lysis and virus neutralization.
about
The varicella-zoster virus immediate-early 63 protein affects chromatin-controlled gene transcription in a cell-type dependent mannerA gammaherpesvirus complement regulatory protein promotes initiation of infection by activation of protein kinase Akt/PKB.Murine gammaherpesvirus 68 encodes a functional regulator of complement activationIn vivo immune evasion mediated by the herpes simplex virus type 1 immunoglobulin G Fc receptor.Herpes simplex virus type 1 glycoprotein gC mediates immune evasion in vivoComplement Evasion Strategies of Viruses: An Overview.Blocking herpes simplex virus 2 glycoprotein E immune evasion as an approach to enhance efficacy of a trivalent subunit antigen vaccine for genital herpes.Complement and viral pathogenesisPoxvirus complement control proteins are expressed on the cell surface through an intermolecular disulfide bridge with the viral A56 protein.Herpes simplex virus type 1 and 2 glycoprotein C prevents complement-mediated neutralization induced by natural immunoglobulin M antibody.A 10 patient case report on the impact of plasmapheresis upon neutralizing factors against adeno-associated virus (AAV) types 1, 2, 6, and 8.Intra-host versus inter-host selection: viral strategies of immune function impairmentImmune evasion properties of herpes simplex virus type 1 glycoprotein gC.Disulfide bond structure determination and biochemical analysis of glycoprotein C from herpes simplex virusA Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell ImmunogensVirulence genes in herpes simplex virus type 1 corneal infection.The vaccinia virus A56 protein: a multifunctional transmembrane glycoprotein that anchors two secreted viral proteinsImmune evasion by herpes simplex virus type 1, strategies for virus survivalIn vivo role of complement-interacting domains of herpes simplex virus type 1 glycoprotein gCExpression of seven herpes simplex virus type 1 glycoproteins (gB, gC, gD, gE, gG, gH, and gI): comparative protection against lethal challenge in mice.Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivityStructural basis of C3b binding by glycoprotein C of herpes simplex virus.Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence.Herpes simplex virus type 1 Fc receptor protects infected cells from antibody-dependent cellular cytotoxicity.A replication-competent, neuronal spread-defective, live attenuated herpes simplex virus type 1 vaccine.Vaccinia virus extracellular enveloped virion neutralization in vitro and protection in vivo depend on complementBlocking immune evasion as a novel approach for prevention and treatment of herpes simplex virus infectionA herpes simplex virus 1 recombinant lacking the glycoprotein G coding sequences is defective in entry through apical surfaces of polarized epithelial cells in culture and in vivoImmunization with HSV-1 glycoprotein C prevents immune evasion from complement and enhances the efficacy of an HSV-1 glycoprotein D subunit vaccineImproving immunogenicity and efficacy of vaccines for genital herpes containing herpes simplex virus glycoprotein D.Viral-derived complement inhibitors: current status and potential role in immunomodulation.Interindividual Spread of Herpesviruses.The complement control protein homolog of herpesvirus saimiri regulates serum complement by inhibiting C3 convertase activity.Herpes simplex virus type 1 infection increases the carbohydrate binding activity and the secretion of cellular galectin-3.The role of human adenovirus early region 3 proteins (gp19K, 10.4K, 14.5K, and 14.7K) in a murine pneumonia model.Cell surface expression of the vaccinia virus complement control protein is mediated by interaction with the viral A56 protein and protects infected cells from complement attack.Inhibition of complement-mediated cytolysis by the terminal complement inhibitor of herpesvirus saimiri.Characterization of domains of herpes simplex virus type 1 glycoprotein E involved in Fc binding activity for immunoglobulin G aggregates.Complement-related proteins in pathogenic organisms.Masters of deception: a review of herpesvirus immune evasion strategies.
P2860
Q33304402-6B381837-8316-4BEE-8933-A61149A1A0FCQ33640201-DDF26958-AF4E-41CA-8AB1-79114C8AC6C2Q33650182-C5DB69FD-F7C7-46B0-9BEA-2C9A8B3160AEQ33784845-270E076D-4CFA-403E-BC5A-6235D6C0DC87Q33784923-5418CD68-5671-44BF-BE54-F8FF1397CB2DQ33804431-4936D59B-9E43-49DC-B211-918DF14A3D9EQ34057952-64295789-8B1B-43AC-A41A-244066F9023DQ34162421-2E8DED21-83F5-4255-965C-C9CCDDF20244Q34190609-4693E6BF-FE6F-4A33-96D1-36D294C52A9EQ34545821-3D1786BC-E670-4F92-82E3-6D0B2FE4C6FCQ35568505-D7E98814-7CF0-4955-92E3-3ADFA64E0BE8Q35680172-39473426-3280-41C1-90DD-A9A67CADAE08Q35863299-D9E11F49-0518-4637-8A49-15CF88E43398Q35866354-D7A3D2B3-6254-46C3-ACB4-8EAE73C75DD8Q35914367-51E32823-D2AC-4558-9C83-858B97E18C51Q35932197-9CDD7DFD-F23E-4B64-914D-A07369955790Q35963805-B86FFAF4-6A6D-41C6-9D90-5B75E31FB9D2Q36372405-236E15ED-9477-43C2-BF7E-5763CD1A0614Q36375668-884E978F-BBB6-4344-B0BD-164933BAEE5CQ36631176-3908B2FC-0EC3-430D-9653-3B197FDC0170Q36681404-7B3E24E6-6733-426C-8D41-055CD30DA83FQ36698675-6992A61F-5A20-4796-8A1A-03CFF4D1834AQ36791349-E614CBE5-4866-429B-B703-06348F19B791Q36829124-DFDFCEA6-5E84-4279-8A12-5BC68555F7CAQ36845870-E01A36D4-D01C-4E35-B836-AF7A07C75FABQ37051617-FA1368CA-8407-4B9A-B2EC-67CF7D46B77FQ37060288-BE2A5955-AA8C-4203-AFD8-D8517E75C5D2Q37119013-5EB02722-EF3A-455F-A83B-7D6286781A93Q37439603-7655C34F-2EDE-4103-A8C0-49D406F541FEQ38241377-B20566C0-8233-4F52-B58D-2ED5205CFFCCQ38995165-A5D1F7F6-C701-4D54-8355-2255ABD606B9Q39320366-D8A1DCEC-FDC1-4056-958B-42A4E31B3D7EQ39870476-6EB92E62-A02D-47C6-B352-61FBB879BA00Q39872004-0267D0FA-E49D-430C-850F-2BB283E504D8Q39874089-C0F70DA7-13E6-4EBC-AF5E-8BBC15BBB2C7Q40011089-28776A60-7305-4CBC-AFCA-4BE10031F9ACQ40038846-696A8A4B-70EF-4F59-8605-5FA84A79D69DQ40040178-A906D9DF-0462-44D7-B142-74F4EBD0450AQ40737570-34D55358-0608-46FE-B1D3-E2F5782C01BAQ41300802-8393D269-9238-490E-AF16-01429D0D642B
P2860
Glycoprotein C of herpes simplex virus type 1 prevents complement-mediated cell lysis and virus neutralization.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Glycoprotein C of herpes simpl ...... ysis and virus neutralization.
@en
type
label
Glycoprotein C of herpes simpl ...... ysis and virus neutralization.
@en
prefLabel
Glycoprotein C of herpes simpl ...... ysis and virus neutralization.
@en
P2093
P356
P1476
Glycoprotein C of herpes simpl ...... ysis and virus neutralization.
@en
P2093
P304
P356
10.1093/INFDIS/162.2.331
P407
P577
1990-08-01T00:00:00Z